No biting the hands that heal them: Animal health industry howls
Petisation. You might be tempted to call it revenge of the lab rats. But the technology developed by Australian animal health company Nexvet Biopharma to adapt monoclonal antibodies (MAbs) developed for humans for use in animals – maintaining efficacy at the proper dose without risk of rejection – takes the lucrative animal health business to the next level.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter